Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

The feasibility of web surveys for obtaining patient-reported outcomes from cancer survivors: a randomized experiment comparing survey modes and brochure enclosures.

Millar MM, Elena JW, Gallicchio L, Edwards SL, Carter ME, Herget KA, Sweeney C.

BMC Med Res Methodol. 2019 Nov 15;19(1):208. doi: 10.1186/s12874-019-0859-9.

2.

Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors.

Guida JL, Ahles TA, Belsky D, Campisi J, Cohen HJ, DeGregori J, Fuldner R, Ferrucci L, Gallicchio L, Gavrilov L, Gavrilova N, Green PA, Jhappan C, Kohanski R, Krull K, Mandelblatt J, Ness KK, O'Mara A, Price N, Schrack J, Studenski S, Theou O, Tracy RP, Hurria A.

J Natl Cancer Inst. 2019 Dec 1;111(12):1245-1254. doi: 10.1093/jnci/djz136.

PMID:
31321426
3.

Envisioning Arti's 'Cadillac study' to assess aging trajectories in cancer survivors.

Guida JL, Green PA, Gallicchio L.

J Geriatr Oncol. 2020 Mar;11(2):175-178. doi: 10.1016/j.jgo.2019.06.009. Epub 2019 Jul 8.

PMID:
31296460
4.

Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity.

Shelburne N, Simonds NI, Adhikari B, Alley M, Desvigne-Nickens P, Dimond E, Filipski K, Gallicchio L, Minasian L.

Curr Oncol Rep. 2019 Jan 30;21(1):9. doi: 10.1007/s11912-019-0751-0. Review.

PMID:
30701318
5.

Survivorship Science at the NIH: Lessons Learned From Grants Funded in Fiscal Year 2016.

Rowland JH, Gallicchio L, Mollica M, Saiontz N, Falisi AL, Tesauro G.

J Natl Cancer Inst. 2019 Feb 1;111(2):109-117. doi: 10.1093/jnci/djy208. Review.

6.

Hormone variability and hot flash experience: Results from the midlife women's health study.

Chiang C, Gallicchio L, Zacur H, Miller S, Flaws JA, Smith RL.

Maturitas. 2019 Jan;119:1-7. doi: 10.1016/j.maturitas.2018.10.007. Epub 2018 Oct 23.

7.

The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature.

Gallicchio L, Gadalla SM, Murphy JD, Simonds NI.

J Natl Cancer Inst. 2018 Oct 1;110(10):1048-1058. doi: 10.1093/jnci/djy189.

8.

Prodrome and Non-prodrome Phenotypes of Bladder Pain Syndrome/Interstitial Cystitis.

Warren JW, Jian N, Gallicchio L, Wu D, Clauw DJ.

Urology. 2018 Aug;118:52-58. doi: 10.1016/j.urology.2018.05.004. Epub 2018 Jun 27.

PMID:
29775697
9.

Trends in Adult Cancer-Related Emergency Department Utilization: An Analysis of Data From the Nationwide Emergency Department Sample.

Rivera DR, Gallicchio L, Brown J, Liu B, Kyriacou DN, Shelburne N.

JAMA Oncol. 2017 Oct 12;3(10):e172450. doi: 10.1001/jamaoncol.2017.2450. Epub 2017 Oct 12.

10.

The Midlife Women's Health Study - a study protocol of a longitudinal prospective study on predictors of menopausal hot flashes.

Ziv-Gal A, Smith RL, Gallicchio L, Miller SR, Zacur HA, Flaws JA.

Womens Midlife Health. 2017 Aug 17;3:4. doi: 10.1186/s40695-017-0024-8. eCollection 2017.

11.

Understanding the complex relationships underlying hot flashes: a Bayesian network approach.

Smith RL, Gallicchio LM, Flaws JA.

Menopause. 2018 Feb;25(2):182-190. doi: 10.1097/GME.0000000000000959.

12.

Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion.

Bove F, Luigetti M, Gallicchio L, Recchia V, Petruzzellis A, Di Iorio R, Tamma F, Fasano A.

Neurol Sci. 2017 Oct;38(10):1869-1872. doi: 10.1007/s10072-017-3029-z. Epub 2017 Jun 22.

PMID:
28642996
13.

Factors Affecting Sexual Function in Midlife Women: Results from the Midlife Women's Health Study.

Smith RL, Gallicchio L, Flaws JA.

J Womens Health (Larchmt). 2017 Sep;26(9):923-932. doi: 10.1089/jwh.2016.6135. Epub 2017 Feb 28.

14.

A prospective study of aromatase inhibitor therapy initiation and self-reported side effects.

Gallicchio L, Calhoun C, Helzlsouer K.

Support Care Cancer. 2017 Sep;25(9):2697-2705. doi: 10.1007/s00520-017-3678-8. Epub 2017 Mar 24.

PMID:
28341972
15.

Response to Dr. Altundag's Letter to the Editor.

Gallicchio L, Calhoun C, Riseberg D, Helzlsouer K.

Breast J. 2017 May;23(3):377. doi: 10.1111/tbj.12794. Epub 2017 Feb 24. No abstract available.

PMID:
28233926
16.

Cardiovascular Health among Black and White Breast Cancer Patients Initiating Aromatase Inhibitor Therapy.

Gallicchio L, Calhoun C, Riseberg D, Helzlsouer K.

Breast J. 2017 Mar;23(2):206-209. doi: 10.1111/tbj.12709. Epub 2016 Oct 25.

PMID:
27779346
17.
18.

Factors Affecting Sexual Activity in Midlife Women: Results from the Midlife Health Study.

Smith RL, Gallicchio L, Flaws JA.

J Womens Health (Larchmt). 2017 Feb;26(2):103-108. doi: 10.1089/jwh.2016.5881. Epub 2016 Sep 21.

19.

Risk Factors for Extended Duration and Timing of Peak Severity of Hot Flashes.

Smith RL, Gallicchio L, Miller SR, Zacur HA, Flaws JA.

PLoS One. 2016 May 5;11(5):e0155079. doi: 10.1371/journal.pone.0155079. eCollection 2016.

20.

Effect of Aromatase Inhibitor Therapy on the Cardiovascular Health of Black and White Breast Cancer Patients.

Gallicchio L, Calhoun C, Helzlsouer K.

Clin Breast Cancer. 2016 Jun;16(3):e23-31. doi: 10.1016/j.clbc.2016.02.011. Epub 2016 Feb 11.

PMID:
26943989
21.

Phthalate metabolite levels and menopausal hot flashes in midlife women.

Ziv-Gal A, Gallicchio L, Chiang C, Ther SN, Miller SR, Zacur HA, Dills RL, Flaws JA.

Reprod Toxicol. 2016 Apr;60:76-81. doi: 10.1016/j.reprotox.2016.02.001. Epub 2016 Feb 8.

22.

Reply To: Sleep Disturbances in Childhood Cancer Survivors.

Ruble K, George A, Gallicchio L, Gamaldo C.

Pediatr Blood Cancer. 2016 Apr;63(4):761. doi: 10.1002/pbc.25880. Epub 2016 Jan 6. No abstract available.

PMID:
26739801
23.

The Associations Between Body Mass Index, Smoking, and Alcohol Intake with Ovarian Volume in Midlife Women.

Gallicchio L, Miller SR, Kiefer J, Greene T, Zacur HA, Flaws JA.

J Womens Health (Larchmt). 2016 Apr;25(4):409-15. doi: 10.1089/jwh.2015.5360. Epub 2015 Dec 14.

24.

Group Physical Activity Intervention for Childhood Cancer Survivors: A Pilot Study.

Ruble K, Scarvalone S, Gallicchio L, Davis C, Wells D.

J Phys Act Health. 2016 Mar;13(3):352-9. doi: 10.1123/jpah.2015-0050. Epub 2015 Aug 13.

PMID:
26284383
25.

Does quitting smoking decrease the risk of midlife hot flashes? A longitudinal analysis.

Smith RL, Flaws JA, Gallicchio L.

Maturitas. 2015 Sep;82(1):123-7. doi: 10.1016/j.maturitas.2015.06.029. Epub 2015 Jun 22.

26.

Change in Pain and Quality of Life Among Women Enrolled in a Trial Examining the Use of Narrow Band Imaging During Laparoscopic Surgery for Suspected Endometriosis.

Gallicchio L, Helzlsouer KJ, Audlin KM, Miller C, MacDonald R, Johnston M, Barrueto FF.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1208-14. doi: 10.1016/j.jmig.2015.06.017. Epub 2015 Jun 30.

PMID:
26140829
27.

Sensitivity of Narrow Band Imaging Compared With White Light Imaging for the Detection of Endometriosis.

Barrueto FF, Audlin KM, Gallicchio L, Miller C, MacDonald R, Alonsozana E, Johnston M, Helzlsouer KJ.

J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):846-52. doi: 10.1016/j.jmig.2015.04.005. Epub 2015 Apr 13.

PMID:
25881884
28.

Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the Midlife Women's Health Study.

Gallicchio L, Miller SR, Kiefer J, Greene T, Zacur HA, Flaws JA.

Menopause. 2015 Oct;22(10):1098-107. doi: 10.1097/GME.0000000000000434.

29.

Association of obesity and sleep problems among breast cancer survivors: results from a registry-based survey study.

Klyushnenkova EN, Sorkin JD, Gallicchio L.

Support Care Cancer. 2015 Dec;23(12):3437-45. doi: 10.1007/s00520-015-2692-y. Epub 2015 Mar 14.

30.

Racial differences in depressive symptoms and self-rated health among breast cancer survivors on aromatase inhibitor therapy.

Calhoun C, Helzlsouer KJ, Gallicchio L.

J Psychosoc Oncol. 2015;33(3):263-77. doi: 10.1080/07347332.2015.1019661.

PMID:
25751493
31.

Sleep disordered breathing risk in childhood cancer survivors: an exploratory study.

Kathy R, Anna G, Gallicchio L, Gamaldo C.

Pediatr Blood Cancer. 2015 Apr;62(4):693-7. doi: 10.1002/pbc.25394. Epub 2015 Jan 19. Erratum in: Pediatr Blood Cancer. 2016 Jan;63(1):180.

32.

Functional somatic syndromes as risk factors for hysterectomy in early bladder pain syndrome/interstitial cystitis.

Warren JW, Clauw DJ, Wesselmann U, Howard FM, Gallicchio L, Morozov V.

J Psychosom Res. 2014 Nov;77(5):363-7. doi: 10.1016/j.jpsychores.2014.09.004. Epub 2014 Sep 16.

PMID:
25258358
33.

Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors.

Olufade T, Gallicchio L, MacDonald R, Helzlsouer KJ.

Support Care Cancer. 2015 Feb;23(2):447-55. doi: 10.1007/s00520-014-2364-3. Epub 2014 Aug 17.

PMID:
25128067
34.

Marital status and optimism score among breast cancer survivors.

Croft L, Sorkin J, Gallicchio L.

Support Care Cancer. 2014 Nov;22(11):3027-34. doi: 10.1007/s00520-014-2308-y. Epub 2014 Jun 8.

35.

Before the onset of interstitial cystitis/bladder pain syndrome, the presence of multiple non-bladder syndromes is strongly associated with a history of multiple surgeries.

Warren JW, Morozov V, Howard FM, Wesselmann U, Gallicchio L, Langenberg P, Clauw DJ.

J Psychosom Res. 2014 Jan;76(1):75-9. doi: 10.1016/j.jpsychores.2013.10.013. Epub 2013 Nov 1.

PMID:
24360145
36.

Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study.

Gallicchio L, Miller SR, Kiefer J, Greene T, Zacur HA, Flaws JA.

J Womens Health (Larchmt). 2014 Mar;23(3):231-7. doi: 10.1089/jwh.2013.4526. Epub 2013 Dec 17.

37.

Association between race and physical functioning limitations among breast cancer survivors.

Gallicchio L, Calhoun C, Helzlsouer KJ.

Support Care Cancer. 2014 Apr;22(4):1081-8. doi: 10.1007/s00520-013-2066-2. Epub 2013 Nov 29.

PMID:
24292017
38.

Aromatase inhibitor therapy and hair loss among breast cancer survivors.

Gallicchio L, Calhoun C, Helzlsouer KJ.

Breast Cancer Res Treat. 2013 Nov;142(2):435-43. doi: 10.1007/s10549-013-2744-2. Epub 2013 Nov 7.

PMID:
24197658
39.

Genetic polymorphisms in the aryl hydrocarbon receptor-signaling pathway and sleep disturbances in middle-aged women.

Ziv-Gal A, Flaws JA, Mahoney MM, Miller SR, Zacur HA, Gallicchio L.

Sleep Med. 2013 Sep;14(9):883-7. doi: 10.1016/j.sleep.2013.04.007. Epub 2013 Jun 13.

40.

Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer.

Gallicchio L, MacDonald R, Helzlsouer KJ.

J Cancer Res Clin Oncol. 2013 May;139(5):837-43. doi: 10.1007/s00432-013-1391-7. Epub 2013 Feb 14.

41.

Shedding light on serum vitamin D concentrations and the risk of rarer cancers.

Helzlsouer KJ, Gallicchio L.

Anticancer Agents Med Chem. 2013 Jan;13(1):65-9.

PMID:
23094922
42.

Genetic polymorphisms in the aryl hydrocarbon receptor signaling pathway as potential risk factors of menopausal hot flashes.

Ziv-Gal A, Gallicchio L, Miller SR, Zacur HA, Flaws JA.

Am J Obstet Gynecol. 2012 Sep;207(3):202.e9-202.e18. doi: 10.1016/j.ajog.2012.05.019. Epub 2012 Jun 1.

43.

Changes in bone biomarker concentrations and musculoskeletal symptoms among breast cancer patients initiating aromatase inhibitor therapy and women without a history of cancer.

Gallicchio L, MacDonald R, Wood B, Rushovich E, Fedarko NS, Helzlsouer KJ.

J Bone Miner Res. 2012 Sep;27(9):1959-66. doi: 10.1002/jbmr.1641.

44.

Reproductive history and hot flashes in perimenopausal women.

Nakano K, Pinnow E, Flaws JA, Sorkin JD, Gallicchio L.

J Womens Health (Larchmt). 2012 Apr;21(4):433-9. doi: 10.1089/jwh.2011.2999. Epub 2012 Jan 27.

45.

Daytime sleepiness and sleep duration in long-term cancer survivors and non-cancer controls: results from a registry-based survey study.

Forsythe LP, Helzlsouer KJ, MacDonald R, Gallicchio L.

Support Care Cancer. 2012 Oct;20(10):2425-32. doi: 10.1007/s00520-011-1358-7. Epub 2012 Jan 5.

PMID:
22218738
46.

Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy.

Gallicchio L, MacDonald R, Wood B, Rushovich E, Helzlsouer KJ.

Climacteric. 2012 Aug;15(4):339-49. doi: 10.3109/13697137.2011.620658. Epub 2011 Dec 23.

PMID:
22191462
47.

A genetic polymorphism in the CYP19A1 gene and the risk of hypertension among midlife women.

Ziv-Gal A, Gallicchio L, Miller SR, Zacur HA, Flaws JA.

Maturitas. 2012 Jan;71(1):70-5. doi: 10.1016/j.maturitas.2011.10.012. Epub 2011 Nov 21.

48.

A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms.

Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E.

Breast Cancer Res Treat. 2012 Jan;131(1):277-85. doi: 10.1007/s10549-011-1729-2. Epub 2011 Sep 9.

PMID:
21904883
49.

Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy.

Gallicchio L, Macdonald R, Wood B, Rushovich E, Helzlsouer KJ.

Breast Cancer Res Treat. 2011 Nov;130(2):569-77. doi: 10.1007/s10549-011-1611-2. Epub 2011 Jun 7.

PMID:
21647676
50.

Somatic symptoms among cosmetologists compared to women in other occupations.

Gallicchio L, Miller SR, Greene T, Zacur H, Flaws JA.

J Womens Health (Larchmt). 2011 Apr;20(4):605-15. doi: 10.1089/jwh.2010.2342. Epub 2011 Mar 18.

PMID:
21417748

Supplemental Content

Loading ...
Support Center